115 related articles for article (PubMed ID: 6722255)
1. Catalysis of the generation of thrombin-antithrombin complex by insoluble anticoagulant polystyrene derivatives.
Fougnot C; Jozefowicz M; Rosenberg RD
Biomaterials; 1984 Mar; 5(2):94-9. PubMed ID: 6722255
[TBL] [Abstract][Full Text] [Related]
2. Interactions of anticoagulant insoluble modified polystyrene resins with plasmatic proteins.
Fougnot C; Jozefowicz M; Bara L; Samama M
Thromb Res; 1982 Oct; 28(1):37-46. PubMed ID: 7157229
[TBL] [Abstract][Full Text] [Related]
3. Adsorption of plasma proteins onto anticoagulant polystyrene derivatives: a fluorescence study.
Dulos E; Dufourcq J; Fougnot C; Jozefowicz M
Biomaterials; 1988 Sep; 9(5):405-12. PubMed ID: 3224125
[TBL] [Abstract][Full Text] [Related]
4. Affinity of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: I. In vitro adsorption studies.
Fougnot C; Jozefowicz M; Rosenberg RD
Biomaterials; 1983 Oct; 4(4):294-8. PubMed ID: 6640057
[TBL] [Abstract][Full Text] [Related]
5. Adsorption of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: II. Competition with the other plasma proteins.
Fougnot C; Jozefowicz M; Rosenberg RD
Biomaterials; 1984 Mar; 5(2):89-93. PubMed ID: 6722254
[TBL] [Abstract][Full Text] [Related]
6. Affinity of antithrombin III for insoluble modified polystyrene.
Boisson C; Gulino D; Jozefonvicz J
Thromb Res; 1987 Apr; 46(1):101-8. PubMed ID: 3590108
[TBL] [Abstract][Full Text] [Related]
7. Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition.
Charef S; Tapon-Bretaudière J; Fischer AM; Pflüger F; Jozefowicz M; Labarre D
Biomaterials; 1996 May; 17(9):903-12. PubMed ID: 8718936
[TBL] [Abstract][Full Text] [Related]
8. Crossed immunoelectrophoresis as applied to studies on complex formation. The binding of heparin to antithrombin III and the antithrombin III--thrombin complex.
Andersson LO; Engman L; Henningsson E
J Immunol Methods; 1977; 14(3-4):271-81. PubMed ID: 557071
[TBL] [Abstract][Full Text] [Related]
9. The catalysis by heparin of the reaction between thrombin and antithrombin.
Evington JR; Feldman PA; Luscombe M; Holbrook JJ
Biochim Biophys Acta; 1986 Mar; 870(1):92-101. PubMed ID: 3947650
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant activity of dextran derivatives.
de Raucourt E; Mauray S; Chaubet F; Maiga-Revel O; Jozefowicz M; Fischer AM
J Biomed Mater Res; 1998 Jul; 41(1):49-57. PubMed ID: 9641623
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin III and heparin inactivation in thrombin involving reactions.
Marciniak E
Thromb Haemost; 1977 Aug; 38(2):486-93. PubMed ID: 579490
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin conformation and the catalytic role of heparin. II. Is the heparin-induced conformational change in antithrombin required for rapid inactivation of thrombin?
Peterson CB; Blackburn MN
J Biol Chem; 1987 Jun; 262(16):7559-66. PubMed ID: 3584127
[TBL] [Abstract][Full Text] [Related]
13. Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. Evidence for a mechanism involving competition with both antithrombin and thrombin for heparin binding.
Peterson CB; Morgan WT; Blackburn MN
J Biol Chem; 1987 Jun; 262(16):7567-74. PubMed ID: 3584128
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
Atkinson HM; Mewhort-Buist TA; Berry LR; Chan AK
Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069
[TBL] [Abstract][Full Text] [Related]
15. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
Elgue G; Blombäck M; Olsson P; Riesenfeld J
Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
[TBL] [Abstract][Full Text] [Related]
16. Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.
Danielsson A; Björk I
Biochem J; 1983 Aug; 213(2):345-53. PubMed ID: 6615439
[TBL] [Abstract][Full Text] [Related]
17. Development of a new laboratory test to evaluate antithrombin resistance in plasma.
Murata M; Takagi A; Suzuki A; Okuyama E; Takagi Y; Ando Y; Kato I; Nakamura Y; Murate T; Matsushita T; Saito H; Kojima T
Thromb Res; 2014 Feb; 133(2):293-8. PubMed ID: 24325876
[TBL] [Abstract][Full Text] [Related]
18. Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III.
Danishefsky I; Ahrens M; Klein S
Biochim Biophys Acta; 1977 Jun; 498(1):215-22. PubMed ID: 560216
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant and antiprotease activities of aprosulate sodium, a new synthetic polyanion, in human plasma and purified systems.
Sugidachi A; Asai F; Koike H
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):773-9. PubMed ID: 7865684
[TBL] [Abstract][Full Text] [Related]
20. Heparin-like tubings. II. Mechanism of the thrombin-antithrombin III reaction at the surface.
Migonney V; Fougnot C; Jozefowicz M
Biomaterials; 1988 May; 9(3):230-4. PubMed ID: 3408793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
